查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1481833

全球薄膜药物製造市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Thin Film Drug Manufacturing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 241 Pages | 商品交期: 最快1-2个工作天内

价格

预计到2032年，全球薄膜药物製造市场的市场规模将从2023年的70.1亿美元达到近168.4亿美元，2024-2032年研究期间的复合年增长率为10.23%。

薄膜药物製造涉及使用专门的製造工艺和设备生产薄膜或包衣的药物剂型。这些薄膜药物递送系统通常由含药物的聚合物基质或涂层组成，它们在口腔或皮肤上快速溶解或崩解，从而能够快速吸收并发挥治疗作用。这些技术包括溶剂浇铸、热熔挤出、喷涂和印刷，能够精确控制薄膜厚度、药物含量和释放动力学。它具有改善患者依从性、增强生物利用度和易于给药等优点，使其适用于各种药物传递途径，包括口服、含服、舌下和透皮给药。

市场动态

对可提高患者依从性、功效和便利性的创新药物输送系统的需求不断增长，推动了薄膜技术的采用。薄膜药物製造可以将药物化合物精确沉积到柔性薄膜基材上，然后可以口服、舌下或透皮给药，以实现快速、受控的药物释放。此技术使得新型剂型的开发成为可能，例如口服可溶膜、透皮贴片和黏膜黏附膜，与传统口服剂型相比，其具有提高生物利用度、减少给药频率和改善掩味等优点。此外，薄膜製造流程（例如溶剂浇铸、热熔挤出和喷墨印刷）的多功能性和可扩展性，使得能够高效生产针对特定患者需求和治疗要求的客製化药物配方和组合产品。此外，心血管疾病、糖尿病和神经退化性疾病等慢性疾病的流行，推动了对有针对性的个人化给药解决方案的需求，以优化治疗结果并最大限度地减少副作用。此外，配方科学、材料工程和药物涂层的进步正在扩大薄膜药物製造在各种治疗领域的能力和应用，包括疼痛管理、荷尔蒙替代疗法和戒烟。此外，学术机构、製药公司和政府机构对研发的投资不断增加，推动了薄膜药物输送系统的创新和技术进步。此外，支持薄膜产品开发和商业化的监管途径和指南的出现，以及创新药物配方的有利报销政策，正在为市场成长创造有利的环境。然而，替代药物传输技术和个人化医疗方法的发展可能会挑战未来几年薄膜药物製造市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球薄膜药物製造市场的每个细分市场进行了包容性评估。薄膜药品製造业的成长和趋势为本研究提供了整体方法。

市场区隔

薄膜药品製造市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助战略家确定相应产品或服务的目标人群以及即将到来的机会。

按产品分类

  • 口腔薄膜（舌下膜、全溶解牙科/颊膜）
  • 透皮薄膜
  • 其他（眼部薄膜等）

按疾病适应症

  • 精神分裂症
  • 偏头痛
  • 阿片类药物依赖
  • 噁心，呕吐
  • 其他的

按配销通路

  • 医院药房
  • 药局
  • 零售药局
  • 电子商务

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲薄膜药物製造市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。薄膜药物製造市场的主要参与者包括辉瑞公司、诺华、威科集团、索尔维、艾伯维、住友製药有限公司、IntelGenx Corp.、NAL Pharma、ZIM Laboratories Limited、Indivior PLC、MonoSol。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：薄膜药品製造 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 依疾病适应症进行的市场吸引力分析
    • 按配销通路分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球薄膜药品製造市场分析：副产品

  • 概述（按产品）
  • 历史和预测数据
  • 按产品分析
  • 口腔薄膜（舌下膜、全溶解牙科/颊膜）
  • 透皮薄膜
  • 其他（眼部薄膜等）

第 6 章：全球薄膜药品製造市场分析：依疾病适应症

  • 按疾病适应症概述
  • 历史和预测数据
  • 按疾病指征分析
  • 精神分裂症
  • 偏头痛
  • 阿片类药物依赖
  • 噁心，呕吐
  • 其他的

第 7 章：全球薄膜药品製造市场分析：按分销管道

  • 配销通路概览
  • 历史和预测数据
  • 按配销通路分析
  • 医院药房
  • 药局
  • 零售药局
  • 电子商务

第 8 章：全球薄膜药品製造市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 9 章：薄膜药品製造公司的竞争格局

  • 薄膜药物製造市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 10 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Pfizer Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Novartis AG
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Wolters Kluwer
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Solvay
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • AbbVie
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Sumitomo Pharma Co. Ltd
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • IntelGenx Corp.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • NAL Pharma
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • ZIM Laboratories Limited
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Indivior PLC
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • MonoSol
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR112114442

The global demand for Thin Film Drug Manufacturing Market is presumed to reach the market size of nearly USD 16.84 Billion by 2032 from USD 7.01 Billion in 2023 with a CAGR of 10.23% under the study period 2024-2032.

Thin film drug manufacturing involves the production of pharmaceutical dosage forms in thin films or coatings using specialized manufacturing processes and equipment. These thin film drug delivery systems typically consist of drug-containing polymer matrices or coatings that dissolve or disintegrate rapidly in the mouth or on the skin, allowing for quick absorption and onset of therapeutic effects. These technologies include solvent casting, hot melt extrusion, spray coating, and printing, which enable precise control over film thickness, drug content, and release kinetics. It offers advantages such as improved patient compliance, enhanced bioavailability, and ease of administration, making them suitable for various routes of drug delivery, including oral, buccal, sublingual, and transdermal administration.

MARKET DYNAMICS

Increasing demand for innovative drug delivery systems that offer improved patient compliance, efficacy, and convenience is fuelling the adoption of thin film technology. Thin film drug manufacturing allows for the precise deposition of pharmaceutical compounds onto a thin, flexible film substrate, which can then be administered orally, sublingually, or transdermally for rapid and controlled drug release. This technology enables the development of novel dosage forms, such as oral dissolvable films, transdermal patches, and mucoadhesive films, which offer advantages such as enhanced bioavailability, reduced dosing frequency, and improved taste masking compared to traditional oral dosage forms. Additionally, the versatility and scalability of thin film manufacturing processes, such as solvent casting, hot-melt extrusion, and inkjet printing, enable efficient production of customized drug formulations and combination products tailored to specific patient needs and therapeutic requirements. Moreover, the spurring prevalence of chronic diseases, such as cardiovascular disorders, diabetes, and neurodegenerative conditions, is driving the demand for targeted and personalized drug delivery solutions that optimize treatment outcomes and minimize side effects. Furthermore, advancements in formulation science, materials engineering, and pharmaceutical coatings are expanding the capabilities and applications of thin film drug manufacturing in various therapeutic areas, including pain management, hormone replacement therapy, and smoking cessation. Additionally, the increasing investment in research and development by academic institutions, pharmaceutical companies, and government agencies drives innovation and technological advancements in thin film drug delivery systems. Furthermore, the emergence of regulatory pathways and guidelines supporting the development and commercialization of thin film products, along with favorable reimbursement policies for innovative drug formulations, are creating a conducive environment for market growth. However, developments in alternative drug delivery technologies and personalized medicine approaches may challenge the thin film drug manufacturing market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Thin Film Drug Manufacturing. The growth and trends of Thin Film Drug Manufacturing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Thin Film Drug Manufacturing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Oral Thin Film (Sublingual Film, Fully Dissolving Dental/Buccal Film)
  • Transdermal Thin Film
  • Others (Ocular Thin Film, etc.)

By Disease Indication

  • Schizophrenia
  • Migraine
  • Opioid Dependence
  • Nausea & Vomiting
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores
  • Retail Pharmacies
  • E-commerce

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Thin Film Drug Manufacturing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Thin Film Drug Manufacturing market include Pfizer Inc., Novartis AG, Wolters Kluwer, Solvay, AbbVie, Sumitomo Pharma Co. Ltd, IntelGenx Corp., NAL Pharma, ZIM Laboratories Limited, Indivior PLC, MonoSol. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. THIN FILM DRUG MANUFACTURING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Disease Indication
    • 3.7.3 Market Attractiveness Analysis By Distribution Channel
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL THIN FILM DRUG MANUFACTURING MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product
  • 5.4. Oral Thin Film (Sublingual Film, Fully Dissolving Dental/Buccal Film) Historic and Forecast Sales By Regions
  • 5.5. Transdermal Thin Film Historic and Forecast Sales By Regions
  • 5.6. Others (Ocular Thin Film, etc.) Historic and Forecast Sales By Regions

6. GLOBAL THIN FILM DRUG MANUFACTURING MARKET ANALYSIS BY DISEASE INDICATION

  • 6.1. Overview By Disease Indication
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Disease Indication
  • 6.4. Schizophrenia Historic and Forecast Sales By Regions
  • 6.5. Migraine Historic and Forecast Sales By Regions
  • 6.6. Opioid Dependence Historic and Forecast Sales By Regions
  • 6.7. Nausea & Vomiting Historic and Forecast Sales By Regions
  • 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL THIN FILM DRUG MANUFACTURING MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 7.1. Overview By Distribution Channel
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Distribution Channel
  • 7.4. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 7.5. Drug Stores Historic and Forecast Sales By Regions
  • 7.6. Retail Pharmacies Historic and Forecast Sales By Regions
  • 7.7. E-commerce Historic and Forecast Sales By Regions

8. GLOBAL THIN FILM DRUG MANUFACTURING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE THIN FILM DRUG MANUFACTURING COMPANIES

  • 9.1. Thin Film Drug Manufacturing Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF THIN FILM DRUG MANUFACTURING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Pfizer Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Novartis AG
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Wolters Kluwer
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Solvay
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. AbbVie
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Sumitomo Pharma Co. Ltd
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. IntelGenx Corp.
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. NAL Pharma
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. ZIM Laboratories Limited
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Indivior PLC
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. MonoSol
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Oral Thin Film (Sublingual Film, Fully Dissolving Dental/Buccal Film) Market Sales By Geography (USD MN)
  • Transdermal Thin Film Market Sales By Geography (USD MN)
  • Others (Ocular Thin Film, etc.) Market Sales By Geography (USD MN)
  • Analysis By Disease Indication (USD MN)
  • Schizophrenia Market Sales By Geography (USD MN)
  • Migraine Market Sales By Geography (USD MN)
  • Opioid Dependence Market Sales By Geography (USD MN)
  • Nausea & Vomiting Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Drug Stores Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • E-commerce Market Sales By Geography (USD MN)
  • Global Thin Film Drug Manufacturing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Thin Film Drug Manufacturing Report
  • Market Research Process
  • Market Research Methodology
  • Global Thin Film Drug Manufacturing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Disease Indication
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Oral Thin Film (Sublingual Film, Fully Dissolving Dental/Buccal Film) Market Sales By Geography (USD MN)
  • Transdermal Thin Film Market Sales By Geography (USD MN)
  • Others (Ocular Thin Film, etc.) Market Sales By Geography (USD MN)
  • Global Market Analysis By Disease Indication (USD MN)
  • Schizophrenia Market Sales By Geography (USD MN)
  • Migraine Market Sales By Geography (USD MN)
  • Opioid Dependence Market Sales By Geography (USD MN)
  • Nausea & Vomiting Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Drug Stores Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • E-commerce Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.